menu search

Larkspur biosciences launches with $35.5 million in financing to build the next precision immunotherapies to outsmart cancer

Addressing the Key Bottlenecks in the Tumor Microenvironment That Allow a Tumor to Subvert the Immune System Financing Co-led by Polaris Innovation Fu...

May 23, 2023, 9:30 am

Mayflower bioventures launches its first spin-out, primera therapeutics, in strategic collaboration with cellectis to develop a gene editing platform to treat mitochondrial diseases

NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Following the formation of Mayflower bioventures, a cell a...

December 29, 2022, 9:30 pm


Search within

Pages Search Results: